Brandon Guthrie, MPH, PhD

Assistant Professor in Global Health and Epidemiology, University of Washington

 

Dr. Brandon Guthrie, MPH, PhD, is an epidemiologist and Assistant Professor of Global Health and Epidemiology at the University of Washington. His specific research interests focus on improving engagement in care among people living with HIV. Dr. Guthrie has NIH-funded research projects based in Nairobi, Kenya that are evaluating interventions to improve linkage and retention in HIV/AIDS care, expedite treatment initiation, and reduce mortality. His research includes both randomized intervention trials as well as mixed methods and implementation science approaches to evaluate interventions that are tailored to achieve both high effectiveness and acceptability. Dr. Guthrie is an instructor in “Advanced Epidemiologic Methods I & II” (Epi 515 and Epi 516) and lecturer in the “Principles of HIV Research” taught in Nairobi, and is the co-director and lecturer in the Epidemiology/Biostatistics module of a fellowship program that trains students in HIV program management, health economics, and health informatics, in collaboration with the University of Nairobi.

Dr. Guthrie’s research interests focus on improving engagement in care among people living with HIV. His NIH-funded research projects are based in Nairobi, Kenya and are evaluating interventions to improve linkage and retention in HIV/AIDS care, expedite treatment initiation, and reduce mortality. His research includes both randomized intervention trials as well as mixed methods and implementation science approaches to evaluate interventions that are tailored to achieve both high effectiveness and acceptability.

Publications

  1. Mbogo, LW, Boyce, CL, Sambai, B, Hawes, SE, Guthrie, BL, Min, WSD et al.. HIV viral non-suppression and drug resistance among persons who inject drugs on dolutegravir antiretroviral therapy in Kenya. medRxiv. 2026; :. doi: 10.64898/2026.02.26.26347230. PubMed PMID:41867239 PubMed Central PMC13004105.
  2. Burdis, NC, Bradford, MC, Heltshe, SL, Milinic, T, McElvaney, OJ, Lease, ED et al.. Elexacaftor/tezacaftor/ivacaftor prescription in lung transplant recipients with cystic fibrosis in the US. J Cyst Fibros. 2025;24 (5):929-934. doi: 10.1016/j.jcf.2025.06.005. PubMed PMID:40603159 PubMed Central PMC12282660.
  3. Zinsli, KA, Krotulski, AJ, Fogarty, MF, Kress, D, Logan, BK, Morgan, A et al.. Substance Use Monitoring Among People Who Use Drugs Using a Novel Assay to Test Dried Blood Spot Specimens. Subst Use Misuse. 2025;60 (9):1382-1390. doi: 10.1080/10826084.2025.2497951. PubMed PMID:40325941 PubMed Central PMC12187533.
  4. Reid, MC, Guthrie, BL, Hajat, A, Glick, SN. National trends in co-use of opioids and methamphetamine among people who inject drugs, 2012-2018. Drug Alcohol Depend. 2025;271 :112630. doi: 10.1016/j.drugalcdep.2025.112630. PubMed PMID:40203668 .
  5. Ellington, LE, Maleche-Obimbo, E, Guthrie, BL, Rosenfeld, M, West, TE, McGrath, CJ et al.. Spirometry Abnormalities and Immune Dysfunction Among Adolescents With and Without HIV in Kenya: A Cohort Study. Chest. 2025;168 (2):449-461. doi: 10.1016/j.chest.2025.02.034. PubMed PMID:40081658 .
Search PubMed